Global Health Data Exchange - Discover the World's Health Data

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm

Nav

General Info
Geography 
Denmark (DNK)
Finland (FIN)
Iceland (ISL)
Ireland (IRL)
Norway (NOR)
Sweden (SWE)
Time period covered 
01/1998 - 12/2004
Citation
Authors 
Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O’Brien E, Ostergren J, ASCOT Investigators
Journal 
Lancet
Volume 
366
Issue 
9489
Pages 
895–906
Publication year 
2005
Suggested citation 
Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O’Brien E, Ostergren J, ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm. Lancet. 2005; 366(9489): 895–906.